Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS: FMT for Ulcerative Colitis
NCT01896635Phase 2Completed
- Sponsor
- University of New South Wales
- Start
- Nov 2013
- Primary completion
- Nov 2015
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in ulcerative colitis (UC), sponsored by University of New South Wales. Started Nov 2013; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01896635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896635.